Latest News

  • INVESTMENT

    6 Apr 2026

    RNA Gets a $2.4B Promotion at Eli Lilly

  • PARTNERSHIPS

    31 Mar 2026

    RNA Meets Cell Therapy, and Texas Is Holding the Handshake

  • REGULATORY

    26 Mar 2026

    No Trial? No Problem. FDA Rewrites the RNA Rules

  • INVESTMENT

    23 Mar 2026

    New Funding Backs Precision in mRNA Medicine

Fatty Bubbles and the $2.25 Billion Peace

Red Moderna logo signage mounted on building exterior above entrance

PARTNERSHIPS

17 Mar 2026

Moderna settles landmark LNP patent dispute for up to $2.25B, securing a royalty-free delivery license for its infectious disease vaccine programs

3D illustration of an mRNA lipid nanoparticle releasing RNA strands into surrounding molecules.

REGULATORY

20 Nov 2025

US MRNA Leaders Push for Regulatory Modernization as Innovation Surges

Moderna, Replicate, and others accelerate mRNA advances as the US faces rising pressure to update its regulatory approach

Technicians working in an mRNA bioprocessing lab with stainless steel bioreactors.

PARTNERSHIPS

18 Nov 2025

New Alliance Aims to Steady the mRNA Supply Chain

Wacker Biotech and RNAV8 Bio join forces to streamline mRNA development and create a more predictable path to the clinic

mRNA strand connecting to virus and syringe representing genetic therapy

INNOVATION

14 Nov 2025

Can mRNA Rewrite the Future of Rare Disease Care?

US labs and biotech firms push mRNA deeper into rare disease therapy, stirring hope and investment

3D illustration of an mRNA strand, syringe, and virus particle symbolizing mRNA research.

INSIGHTS

10 Nov 2025

What BioNTech’s CureVac Deal Says About mRNA’s Future

BioNTech’s $1.25B CureVac deal pushes mRNA beyond vaccines toward cancer treatment

AbbVie corporate building exterior symbolizing major expansion into in-vivo mRNA therapies

PARTNERSHIPS

20 Aug 2025

Inside AbbVie's High-Stakes Deal on Next-Gen mRNA Therapy

AbbVie's Capstan buy signals a bold leap into in-vivo mRNA therapies, reshaping the race for next-gen autoimmune treatments.

Scientist analyzing samples with digital DNA displays representing mRNA cancer research

RESEARCH

14 Aug 2025

Early Cancer Trial Puts mRNA in the Spotlight

Strand's STX-001 shows early tumor-fighting promise as mRNA shifts from vaccines to therapeutics.

SUBSCRIBE FOR UPDATES

By submitting, you agree to receive email communications from the event organizers, including upcoming promotions and discounted tickets, news, and access to related events.